Showing 20 of 25 recruiting trials for “high-grade-astrocytoma”
Tuvusertib in Astrocytoma With ATRX Mutation
👨⚕️ Estela Pineda, M.D.; Ph.D., Medical Oncology, Hospital Clínic de Barcelona📍 10 sites📅 Started Dec 2025View details ↗
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
👨⚕️ Elaine T Kiriakopoulos, MD, MPH, MSc, Dartmouth-Health/Dartmouth-Hitchcock, Dartmouth College📍 1 site📅 Started Nov 2025View details ↗
Study of How Safe and Effective Tarlatamab is in Brain Cancers
👨⚕️ Eric Chen, MD, Princess Margaret Cancer Centre/University Health Network📍 1 site📅 Started Aug 2025View details ↗
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma
👨⚕️ Erin K Barr, Pediatric Early Phase Clinical Trial Network📍 17 sites📅 Started Jun 2025View details ↗
Study of Olutasidenib and Temozolomide in HGG
RecruitingNCT06915649 ↗
Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingNCT05839379 ↗
Targeted Pediatric High-Grade Glioma Therapy
DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
👨⚕️ Howard Colman, MD, PhD, Huntsman Cancer Institute/ University of Utah📍 8 sites📅 Started Jul 2023View details ↗
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Study of Pembrolizumab and M032 (NSC 733972)
👨⚕️ James Markert, MD, The University of Alabama at Birmingham📍 1 site📅 Started Feb 2022View details ↗
Implantable Microdevice In Primary Brain Tumors
👨⚕️ Pier Paolo Peruzzi, MD, PhD, Brigham and Women's Hospital📍 1 site📅 Started Mar 2020View details ↗
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →